Press Room CDMO world Announces Strategic Media Partnership with Informa Markets to Support Global Pharmaceutical Events CDMO world to bring it's Field Intelligence Studio to CPHI America May 21, 2026
In the Field Global Clinical Supplies Group Annual Meeting Field Intelligence Report Greetings from the field! San Diego is not only a great city, but this year it is host to the Global Clinical Supplies Group… May 5, 2026
In the Field DCAT Week 2026 Recap The CDMO World team recently returned from DCAT Week, held March 23–26 across New York City, where five team members—Kevin Bittorf, Ray Sison, Emma… April 10, 2026
Company Announcements Evotec and Sandoz Explore $300M Biologics Unit Sale in Toulouse: CDMO Capacity Shifts Evotec has entered a non-binding agreement with Sandoz to explore the $300M sale of its Toulouse biologics facility, signaling shifts in CDMO capacity and… March 27, 2026
In the Field Day 2 at DCAT: The Moments In Between Day 2 of DCAT Week is in full swing, and the CDMO World team is still going strong in New York City. Between insightful… March 24, 2026
In the Field At SXSW Great conversations and new ideas coming out of South by Southwest this week in Austin. Stopped by Shokworks, Inc. hosted an event during SXSW… March 24, 2026
In the Field Kevin’s Shoes Kevin Bittorf from CDMOworld is on the ground this week at South by Southwest Services in Austin, scouting the intersection of innovation, biotech, AI… March 24, 2026
In the Field Ray at BioProcess International Great to see Ray Sison, Editor-at-Large at @CDMOworld, speak this week at BioProcess International in San Diego. Ray is on the ground connecting with… March 24, 2026
In the Field Day One in the Big Apple: CDMO World Kicks Off DCAT Week in NYC DCAT Week is officially underway, and CDMO World is on the ground in New York City for one of the most important gatherings in… March 23, 2026
Company Announcements Evotec Refines 2025 Revenue Projections While Upholding Profit Targets: CDMO Market Implications Evotec has revised its fiscal 2025 revenue forecast but left its R&D and adjusted EBITDA targets unchanged, a move with broad implications for CDMO… March 9, 2026
